These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 17241469)
1. Evaluation and significance of hyperchromatic crowded groups (HCG) in liquid-based paps. Chivukula M; Austin RM; Shidham VB Cytojournal; 2007 Jan; 4():2. PubMed ID: 17241469 [TBL] [Abstract][Full Text] [Related]
2. Detection of Chaump M; Pirog EC; Panico VJ; D Meritens AB; Holcomb K; Hoda R Cytojournal; 2016; 13():28. PubMed ID: 28105064 [TBL] [Abstract][Full Text] [Related]
3. Reducing or eliminating use of the category of atypical squamous cells of undetermined significance decreases the diagnostic accuracy of the Papanicolaou smear. Pitman MB; Cibas ES; Powers CN; Renshaw AA; Frable WJ Cancer; 2002 Jun; 96(3):128-34. PubMed ID: 12115299 [TBL] [Abstract][Full Text] [Related]
4. Cytomorphological Features of Hyperchromatic Crowded Groups in Liquid-Based Cervicovaginal Cytology: A Single Institutional Experience. Lee Y; Lee C; Park IA; An HJ; Kim H J Pathol Transl Med; 2019 Nov; 53(6):393-398. PubMed ID: 31525835 [TBL] [Abstract][Full Text] [Related]
5. Adjunctive high-risk human papillomavirus DNA testing is a useful option for disease risk assessment in patients with negative Papanicolaou tests without an endocervical/transformation zone sample. Zhao C; Austin RM Cancer; 2008 Aug; 114(4):242-8. PubMed ID: 18484643 [TBL] [Abstract][Full Text] [Related]
7. Use of a liquid-based, thin-layer Pap test in a community hospital. Impact on cytology performance and productivity. Sass MA Acta Cytol; 2004; 48(1):17-22. PubMed ID: 14969176 [TBL] [Abstract][Full Text] [Related]
8. "Low-grade squamous intraepithelial lesion, cannot exclude high-grade:" TBS says "Don't Use It!" should I really stop it? Chiaffarano JM; Alexander M; Rogers R; Zhou F; Cangiarella J; Yee-Chang M; Elgert P; Simsir A Cytojournal; 2017; 14():13. PubMed ID: 28603542 [TBL] [Abstract][Full Text] [Related]
9. Accuracy of cervical cytology: comparison of diagnoses of 100 Pap smears read by four pathologists at three hospitals in Norway. Sørbye SW; Suhrke P; Revå BW; Berland J; Maurseth RJ; Al-Shibli K BMC Clin Pathol; 2017; 17():18. PubMed ID: 28860942 [TBL] [Abstract][Full Text] [Related]
10. Impact of ASC-H terminology on the detection of HSILs in medically underserved California women. Howell LP; Gurusinghe S; Tabnak F Diagn Cytopathol; 2009 Feb; 37(2):103-10. PubMed ID: 19021201 [TBL] [Abstract][Full Text] [Related]
11. Prevalence and predictors of Pap smear cervical epithelial cell abnormality among HIV-positive and negative women attending gynecological examination in cervical cancer screening center at Debre Markos referral hospital, East Gojjam, Northwest Ethiopia. Getinet M; Gelaw B; Sisay A; Mahmoud EA; Assefa A BMC Clin Pathol; 2015; 15():16. PubMed ID: 26401120 [TBL] [Abstract][Full Text] [Related]
12. Should LSIL with ASC-H (LSIL-H) in cervical smears be an independent category? A study on SurePath specimens with review of literature. Shidham VB; Kumar N; Narayan R; Brotzman GL Cytojournal; 2007 Mar; 4():7. PubMed ID: 17374161 [TBL] [Abstract][Full Text] [Related]
13. Cytological variations and typical diagnostic features of endocervical adenocarcinoma in situ: A retrospective study of 74 cases. Umezawa T; Umemori M; Horiguchi A; Nomura K; Takahashi H; Yamada K; Ochiai K; Okamoto A; Ikegami M; Sawabe M Cytojournal; 2015; 12():8. PubMed ID: 25972909 [TBL] [Abstract][Full Text] [Related]
14. Utility of P16 expression and Ki-67 proliferation index in ASCUS and ASC-H pap tests. Toll AD; Kelly D; Maleki Z Diagn Cytopathol; 2014 Jul; 42(7):576-81. PubMed ID: 24288264 [TBL] [Abstract][Full Text] [Related]
15. Application of bethesda system for cervical cytology in unhealthy cervix. Verma I; Jain V; Kaur T J Clin Diagn Res; 2014 Sep; 8(9):OC26-30. PubMed ID: 25386491 [TBL] [Abstract][Full Text] [Related]
16. Is a liquid-based cytology more sensitive than a conventional Pap smear? Sigurdsson K Cytopathology; 2013 Aug; 24(4):254-63. PubMed ID: 23331613 [TBL] [Abstract][Full Text] [Related]
17. Screening for cervical disease in mature women: strategies for improvement. Colgan TJ; Clarke A; Hakh N; Seidenfeld A Cancer; 2002 Aug; 96(4):195-203. PubMed ID: 12209660 [TBL] [Abstract][Full Text] [Related]
18. Lack of transformation zone in cervical Pap tests, should it be a concern? A quality assurance initiative. Polanco Jacome EC; Maerki J; Chau K; Akerman M; Sajjan S; Klein M; Gimenez C; Laser A; Das K Diagn Cytopathol; 2018 Jul; 46(7):584-588. PubMed ID: 29722175 [TBL] [Abstract][Full Text] [Related]